Literature DB >> 11986107

Reliability of proton and goldmann applanation tonometers in normal and postkeratoplasty eyes.

Surinder S Pandav1, Ashok Sharma, Amit Gupta, Suresh K Sharma, Amod Gupta, Bijayananda Patnaik.   

Abstract

OBJECTIVE: To compare the reliability of intraocular pressure (IOP) measurements with the ProTon tonometer and the Goldmann applanation tonometer (GAT) in normal and post-penetrating keratoplasty (post-PK) eyes.
DESIGN: Prospective, nonrandomized, comparative case series. PARTICIPANTS: Twenty-four individuals (48 eyes) with no known ocular disorder and 59 patients (59 eyes) that had undergone penetrating keratoplasty (PK) were included in the normal and post-PK groups, respectively.
METHODS: Three readings at 5-minute intervals each were obtained with GAT and ProTon in both the groups. Each reading with ProTon was a mean of five accepted readings with the highest accuracy (standard error of mean, <0.5 mmHg). In post-PK eyes with more than 3.00 diopters of astigmatism or with irregular astigmatism, the mean of two readings taken with GAT in the steepest and flattest axis was considered to be the IOP. MAIN OUTCOME MEASURES: The IOP measurements in all groups were compared using a two-tail paired t test. The coefficient of repeatability and Cronbach's coefficient alpha were calculated separately for the IOP measured using both instruments in each group.
RESULTS: There was no significant difference in the second (r1) and third (r2) IOP reading using the GAT and ProTon tonometers in normal and post-PK eyes. The coefficients of repeatability for GAT and ProTon were 2.64 and 2.49 in normal versus 3.72 and 3.47 in the post-PK group. The Cronbach's alpha for GAT and ProTon was 0.94 and 0.95 in the normal group versus 0.95 for both GAT and ProTon in the post-PK group.
CONCLUSIONS: The results of our study show that the ProTon tonometer is reliable and comparable with GAT for recording IOP in normal and post-PK eyes.

Entities:  

Mesh:

Year:  2002        PMID: 11986107     DOI: 10.1016/s0161-6420(02)00974-0

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  7 in total

1.  Comparison of efficacy of four prostaglandin analogues by bilateral treatment in healthy subjects.

Authors:  Ichiro Kawaguchi; Tomomi Higashide; Shinji Ohkubo; Chiaki Kawaguchi; Kazuhisa Sugiyama
Journal:  Jpn J Ophthalmol       Date:  2012-06-07       Impact factor: 2.447

2.  A comparison of four methods of tonometry: method agreement and interobserver variability.

Authors:  P-A Tonnu; T Ho; K Sharma; E White; C Bunce; D Garway-Heath
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

3.  Comparison of IOP measurement using GAT and DCT in patients with penetrating keratoplasties.

Authors:  A R Ismail; M Lamont; S Perera; D Khan-Lim; R Mehta; J D A Macleod; D F Anderson
Journal:  Br J Ophthalmol       Date:  2007-07       Impact factor: 4.638

4.  Comparison of iCare tonometer and Goldmann applanation tonometry in normal corneas and in eyes with automated lamellar and penetrating keratoplasty.

Authors:  M L Salvetat; M Zeppieri; F Miani; C Tosoni; L Parisi; P Brusini
Journal:  Eye (Lond)       Date:  2011-03-25       Impact factor: 3.775

Review 5.  Graft failure: III. Glaucoma escalation after penetrating keratoplasty.

Authors:  Emily C Greenlee; Young H Kwon
Journal:  Int Ophthalmol       Date:  2008-06       Impact factor: 2.031

6.  Repeatability of the Novel Intraocular Pressure Measurement From Corvis ST.

Authors:  Masato Matsuura; Hiroshi Murata; Yuri Fujino; Mieko Yanagisawa; Yoshitaka Nakao; Shunsuke Nakakura; Yoshiaki Kiuchi; Ryo Asaoka
Journal:  Transl Vis Sci Technol       Date:  2019-06-24       Impact factor: 3.283

7.  Evaluation of rebound tonometer iCare IC200 as compared with IcarePRO and Goldmann applanation tonometer in patients with glaucoma.

Authors:  Shunsuke Nakakura; Ryo Asaoka; Etsuko Terao; Yuki Nagata; Yasuko Fukuma; Satomi Oogi; Miku Shiraishi; Yoshiaki Kiuchi
Journal:  Eye Vis (Lond)       Date:  2021-07-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.